Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
ZYXI

ZYXI - Zynex Inc Stock Price, Fair Value and News

9.00USD-0.13 (-1.42%)Market Closed

Market Summary

ZYXI
USD9.00-0.13
Market Closed
-1.42%

ZYXI Alerts

  • Big fall in earnings (Y/Y)

ZYXI Stock Price

View Fullscreen

ZYXI RSI Chart

ZYXI Valuation

Market Cap

286.0M

Price/Earnings (Trailing)

34.99

Price/Sales (Trailing)

1.52

EV/EBITDA

25.54

Price/Free Cashflow

17.11

ZYXI Price/Sales (Trailing)

ZYXI Profitability

EBT Margin

5.82%

Return on Equity

24.69%

Return on Assets

6.47%

Free Cashflow Yield

5.84%

ZYXI Fundamentals

ZYXI Revenue

Revenue (TTM)

188.7M

Rev. Growth (Yr)

10.34%

Rev. Growth (Qtr)

-1.59%

ZYXI Earnings

Earnings (TTM)

8.2M

Earnings Growth (Yr)

-99.36%

Earnings Growth (Qtr)

-99.18%

Breaking Down ZYXI Revenue

Last 7 days

-6.1%

Last 30 days

-18.3%

Last 90 days

-28.3%

Trailing 12 Months

-5.0%

How does ZYXI drawdown profile look like?

ZYXI Financial Health

Current Ratio

3.58

Debt/Equity

1.75

Debt/Cashflow

0.31

ZYXI Investor Care

Buy Backs (1Y)

13.31%

Diluted EPS (TTM)

0.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024188.7M000
2023169.3M177.4M185.8M184.3M
2022137.3M143.0M149.7M158.2M
202189.0M100.8M115.5M130.3M
202051.5M60.5M68.7M80.1M
201934.2M37.0M40.6M45.5M
201826.9M29.4M30.7M31.9M
201713.3M15.0M18.2M23.4M
201611.9M12.1M13.1M13.3M
201511.1M12.9M11.1M11.6M
201417.2M13.1M12.3M11.1M
201338.4M33.9M29.0M21.7M
201236.5M38.1M38.8M39.7M
201126.6M29.1M31.6M34.1M
201000024.1M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Zynex Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 05, 2024
moorhead daniel j
acquired
-
-
5,000
chief financial officer
Jun 05, 2024
moorhead daniel j
sold (taxes)
-42,792
9.64
-4,439
chief financial officer
May 16, 2024
cress michael d
acquired
-
-
10,000
-
May 16, 2024
disbrow joshua r.
acquired
-
-
10,000
-
May 16, 2024
michaels barry d
acquired
-
-
10,000
-
Apr 30, 2024
moorhead daniel j
acquired
-
-
2,563
chief financial officer
Apr 30, 2024
sandgaard thomas
acquired
-
-
2,563
president, ceo and chairman

1–10 of 50

Which funds bought or sold ZYXI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 24, 2024
Cetera Investment Advisers
new
-
345,605
345,605
-%
May 20, 2024
CIM, LLC
added
0.31
-19,708
508,073
0.08%
May 17, 2024
Aspect Partners, LLC
unchanged
-
488
4,082
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-38.9
-9,996
22,674
-%
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-294,107
-
-%
May 16, 2024
HANCOCK WHITNEY CORP
added
24.93
120,207
407,013
0.01%
May 15, 2024
Quarry LP
sold off
-100
-4,400
-
-%
May 15, 2024
Point72 Asset Management, L.P.
sold off
-100
-6,534
-
-%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-97.65
-79,053
2,165
-%
May 15, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
unchanged
-
850,000
7,111,000
0.01%

1–10 of 45

Are Funds Buying or Selling ZYXI?

Are funds buying ZYXI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ZYXI
No. of Funds

Unveiling Zynex Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Oct 06, 2023
blackrock inc.
4.1%
1,477,842
SC 13G/A
May 24, 2023
sandgaard thomas
44.6%
16,331,423
SC 13D/A
Feb 01, 2023
blackrock inc.
9.1%
3,396,632
SC 13G/A
Feb 07, 2022
blackrock inc.
8.7%
3,035,364
SC 13G/A
Feb 02, 2021
blackrock inc.
8.3%
2,900,347
SC 13G
Dec 02, 2020
sandgaard thomas
43.66%
15,281,821
SC 13D/A
Jul 20, 2020
sandgaard thomas
36.5%
15,256,642
SC 13D/A
Mar 04, 2020
sandgaard thomas
42.84%
16,631,392
SC 13D/A

Recent SEC filings of Zynex Inc

View All Filings
Date Filed Form Type Document
Jun 05, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 16, 2024
8-K
Current Report
May 02, 2024
4
Insider Trading
May 02, 2024
4
Insider Trading
Apr 30, 2024
8-K
Current Report
Apr 30, 2024
4
Insider Trading
Apr 30, 2024
10-Q
Quarterly Report

Peers (Alternatives to Zynex Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
180.4B
40.3B
-0.87% -1.28%
32.05
4.47
-2.84% -3.00%
67.6B
19.7B
-1.49% -8.74%
50.68
3.43
4.82% -17.56%
19.3B
3.9B
-8.68% -23.17%
41.69
4.92
5.72% 46.72%
17.2B
14.9B
-4.71% -24.07%
6.49
1.16
2.98% 207.68%
MID-CAP
9.6B
3.5B
-1.72% 24.73%
30.66
2.71
6.16% 35.06%
8.4B
12.4B
-11.97% -13.19%
21.71
0.68
-0.93% -18.83%
8.1B
2.6B
-6.15% -25.48%
-24.99
3.09
-6.25% -68.58%
5.4B
3.9B
-7.61% -31.99%
-56.77
1.38
0.23% 90.80%
3.4B
387.1M
-0.71% 28.31%
-215.21
8.86
30.82% 65.57%
2.0B
6.6B
-12.43% -18.98%
10.47
0.31
2.78% -0.87%
SMALL-CAP
1.5B
3.2B
15.14% 13.53%
-2.17
0.46
7.94% -1695.32%
390.3M
169.3M
0.92% -1.83%
-5.08
2.31
7.49% -244.90%
246.7M
324.0M
-3.14% -43.23%
-1.28
0.76
-3.19% -337.41%
50.2M
50.5M
2.84% -79.14%
-2.2
1
14.25% -10.06%
1.8M
3.7M
75.00% -80.56%
-0.15
0.49
5.77% 8.23%

Zynex Inc News

Latest updates
Defense World14 hours ago
Yahoo Finance12 Jun 202401:40 pm
Yahoo Finance27 May 202407:00 am
PR Newswire30 Apr 202407:00 am
Seeking Alpha30 Apr 202407:00 am

Zynex Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-1.6%47.0047.0050.0045.0042.0049.0042.0037.0031.0040.0035.0031.0024.0026.0020.0019.0015.0014.0012.0010.009.00
Costs and Expenses2.3%46.0045.0044.0042.0042.0039.0035.0032.0029.0029.0027.0027.0025.0023.0019.0015.0013.0010.009.008.007.00
  S&GA Expenses7.9%23.0022.0022.0022.0021.0019.0017.0016.0014.0014.0013.0014.0014.0012.009.007.006.005.004.003.002.00
EBITDA Margin-16.1%0.06*0.08*0.12*0.13*0.14*0.15*0.17*0.19*0.20*0.19*0.13*0.08*---------
Interest Expenses-39.9%-0.51-0.37-0.33-0.32-0.08-0.09-0.11-0.11-0.12-0.02-0.02-0.04-0.010.000.000.000.00-0.010.00--
Income Taxes-99.8%0.001.001.001.000.002.002.001.001.003.002.001.00-0.380.000.001.00-0.501.000.000.001.00
Earnings Before Taxes-99.3%0.002.005.004.002.0010.006.004.002.0012.008.004.00-1.092.001.004.002.004.002.003.003.00
EBT Margin-14.7%0.06*0.07*0.11*0.12*0.13*0.14*0.16*0.18*0.18*0.17*0.11*0.06*---------
Net Income-99.2%0.001.004.003.002.007.005.003.001.009.006.003.00-0.712.001.003.003.003.002.002.002.00
Net Income Margin-18.0%0.04*0.05*0.09*0.10*0.10*0.11*0.12*0.14*0.14*0.13*0.09*0.05*---------
Free Cashflow-65.9%2.006.009.001.002.005.007.00-0.322.007.004.001.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-7.8%12613715115311111611512013213391.0084.0070.0072.0065.0037.0033.0028.0025.0022.0019.00
  Current Assets-11.2%78.0088.0010310865.0070.0067.0071.0082.0083.0070.0062.0061.0063.0058.0030.0026.0023.0019.0016.0014.00
    Cash Equivalents-26.3%33.0045.0043.0059.0017.0020.0024.0027.0039.0043.0035.0032.0033.0039.0041.0017.0015.0014.0012.0010.009.00
  Inventory18.1%15.0013.0014.0014.0014.0013.0014.0015.0013.0011.009.0010.0011.009.006.005.003.002.002.001.002.00
  Net PPE3.9%3.003.002.002.002.002.002.002.002.002.002.002.002.002.002.001.001.001.001.001.001.00
  Goodwill0%20.0020.0020.0020.0020.0020.0020.0020.0020.0020.00-----------
Liabilities2.6%93.0091.0093.0090.0047.0050.0050.0051.0056.0059.0027.0026.0014.0015.0011.0010.0010.009.008.008.007.00
  Current Liabilities17.4%22.0019.0020.0014.0021.0021.0020.0019.0022.0023.0010.009.009.0010.007.006.006.005.005.004.004.00
  Short Term Borrowings-----5.005.005.005.00-5.00-----------
  Long Term Debt0.4%58.0058.0057.0057.004.00-7.008.009.0011.00-----------
    LT Debt, Non Current0.4%58.0058.0057.0057.00-----------------
Shareholder's Equity-28.2%33.0046.0059.0062.0064.0066.0065.0069.0076.0074.0063.0057.0056.0057.0054.0027.0023.0020.0016.0014.0012.00
  Retained Earnings0.0%27.0027.0026.0022.0019.0017.0010.005.001.00-32.0026.0023.0023.0022.0020.0017.0014.0011.009.007.00
  Additional Paid-In Capital0.4%91.0091.0091.0083.0082.0082.0082.0081.0081.0080.0038.0038.0037.0037.0036.0011.0010.009.009.009.008.00
Shares Outstanding-3.2%32.0033.0034.0036.0037.0037.0038.0039.0040.0040.0038.0038.00---------
Minority Interest----------------0.09-0.09-0.09-0.09-0.09-0.09-0.09
Float----205---175---308---422---292-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-66.6%2,0686,1888,8937411,9344,7577,411-1761,7547,5383,6891,027-5,305-1,696-7692,6516322,0981,8416001,764
  Share Based Compensation8.7%734675654660307640578535589588533401108875730579497264258158140
Cashflow From Investing-101.6%-1539,424-10,006-210-174-86.00-120-140-72.00-16,186-66.00-55.00-299-226-105-357-297-28.009.00-95.00-46.00
Cashflow From Financing-0.6%-13,633-13,550-15,11941,426-5,112-8,059-10,636-12,054-5,04715,892-585-2,081-130-13425,18737.0021036.0030.00130-2,427
  Dividend Payments50.0%3.002.00------3,6131.00--------3.00-2,259
  Buy Backs38.3%13,2809,60014,9346,1153,3536,6009,15610,655--1,0395472,04575.00--------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ZYXI Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
NET REVENUE  
Total net revenue$ 46,531,000$ 42,170,000
COSTS OF REVENUE AND OPERATING EXPENSES  
Costs of revenue - devices and supplies9,298,0009,269,000
Sales and marketing23,380,00021,227,000
General and administrative13,328,00011,390,000
Total costs of revenue and operating expenses46,006,00041,886,000
Income from operations525,000284,000
Other income (expense)  
Gain on sale of fixed assets 2,000
Gain on change in fair value of contingent consideration 1,400,000
Interest expense, net(512,000)(84,000)
Other income (expense), net(512,000)1,318,000
Income from operations before income taxes13,0001,602,000
Income tax expense3,00033,000
Net income$ 10,000$ 1,569,000
Net income per share:  
Basic (in dollars per share)$ 0.00$ 0.04
Diluted (in dollars per share)$ 0.00$ 0.04
Weighted average basic shares outstanding (in shares)32,34436,694
Weighted average diluted shares outstanding (in shares)32,82737,442
Devices  
NET REVENUE  
Total net revenue$ 14,025,000$ 11,944,000
Supplies  
NET REVENUE  
Total net revenue$ 32,506,000$ 30,226,000

ZYXI Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 32,861$ 44,579
Accounts receivable, net25,43926,838
Inventory, net15,47613,106
Prepaid expenses and other4,2133,332
Total current assets77,98987,855
Property and equipment, net3,2343,114
Operating lease asset11,85712,515
Finance lease asset537587
Deposits409409
Intangible assets, net of accumulated amortization7,9328,158
Goodwill20,40120,401
Deferred income taxes3,8663,865
Total assets126,225136,904
Current liabilities:  
Accounts payable and accrued expenses10,3258,433
Operating lease liability3,8813,729
Finance lease liability183196
Income taxes payable637633
Accrued payroll and related taxes6,7295,541
Total current liabilities21,75518,532
Long-term liabilities:  
Convertible senior notes, less issuance costs57,83957,605
Operating lease liability13,18414,181
Finance lease liability347457
Total liabilities93,12590,775
Commitments and contingencies
Stockholders' equity:  
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common stock, $0.001 par value; 100,000,000 shares authorized; 42,048,385 issued and 31,879,892 outstanding as of March 31, 2024. 41,980,166 issued and 32,933,776 outstanding as of December 31, 2023.3233
Additional paid-in capital91,25990,878
Treasury stock of 9,666,879 and 8,545,044 shares at March 31, 2024 and December 31, 2023, respectively, at cost(84,981)(71,562)
Retained earnings26,79026,780
Total stockholders' equity33,10046,129
Total liabilities and stockholders' equity$ 126,225$ 136,904
ZYXI
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
 CEO
 WEBSITEzynex.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES900

Zynex Inc Frequently Asked Questions


What is the ticker symbol for Zynex Inc? What does ZYXI stand for in stocks?

ZYXI is the stock ticker symbol of Zynex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zynex Inc (ZYXI)?

As of Fri Jun 14 2024, market cap of Zynex Inc is 285.98 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZYXI stock?

You can check ZYXI's fair value in chart for subscribers.

What is the fair value of ZYXI stock?

You can check ZYXI's fair value in chart for subscribers. The fair value of Zynex Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Zynex Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ZYXI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Zynex Inc a good stock to buy?

The fair value guage provides a quick view whether ZYXI is over valued or under valued. Whether Zynex Inc is cheap or expensive depends on the assumptions which impact Zynex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZYXI.

What is Zynex Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 14 2024, ZYXI's PE ratio (Price to Earnings) is 34.99 and Price to Sales (PS) ratio is 1.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZYXI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zynex Inc's stock?

In the past 10 years, Zynex Inc has provided 0.429 (multiply by 100 for percentage) rate of return.